What is the Return on Assets (ROA) of Precigen this year?
The Return on Assets (ROA) of Precigen is -0.63 undefined this year.
Precigen ROA 2024
Precigen ROA
-0.63
Ticker
PGEN
ISIN
US74017N1054
WKN
A2PZG1
In 2024, Precigen's return on assets (ROA) was -0.63, a -584.62% increase from the 0.13 ROA in the previous year.
Precigen Aktienanalyse
What does Precigen do?
Precigen Inc is a biotechnology company headquartered in Germantown, Maryland, USA. The company was founded in 1991 under the name Human Genome Sciences Inc and became the first company in the industry to unlock genetic genes for drug development. In 2019, the company was renamed Precigen Inc. The company specializes in the development of cell and gene therapy products based on the latest advances in regenerative medicine. The goal is to treat diseases that have been difficult or even considered incurable through gene therapy, genome sequencing, and artificial intelligence. Precigen is divided into several divisions: Precigen ActoBio, Precigen Genome, Precigen RegenX, and Precigen Triple Gem. The divisions differ in product development and target application areas. Precigen ActoBio focuses on the development of biological therapies for autoimmune diseases. The company is working on an oral immunotherapy that can treat respiratory and inflammatory bowel diseases. The product is in the testing phase and if all goes well, approval could be within reach. Precigen Genome specializes in genome sequencing. The data from the genes is decoded to develop better medical diagnoses and therapies. Precigen Genome's services range from sequencing genomic information to uncovering further details to interpreting genome data. Precigen RegenX develops gene therapy products for the treatment of rare but severe genetic diseases. The aim is to modify specific genes in the body to achieve a cure or alleviate symptoms. An example of a product from Precigen RegenX is a gene therapy for hemophilia. This product is being tested in phase II clinical trials and could represent a true revolution in treatment. Precigen Triple Gem is the company's newest division, founded in 2020. It is a research and development project focused on novel cancer therapies. The main focus is on the development of CAR-T cells that can recognize and destroy various types of cancer cells. The company has already achieved promising results. The products from Precigen aim to simplify the treatment of severe diseases and minimize side effects through integration into molecular medicine. Patient safety is the top priority. To ensure this, strict testing phases are undergone and there is close monitoring of product development. Precigen's business strategy is based on collaboration with other companies and institutions. The company works with large pharmaceutical companies to support production, distribution, and marketing of the products, among other partnerships. Another important partnership is with universities and research institutions, which help the company in developing new technologies, improving production processes, and conducting clinical trials. This collaboration leads to faster research insights and a larger pool of knowledge and know-how. Precigen is also committed to recruiting the best talent and qualified personnel in the field of biotechnology. Overall, Precigen is an extremely innovative and promising company in the field of regenerative medicine and gene therapy. The company relies on a clever business strategy and forward-thinking partnerships to develop even better therapies for serious, previously incurable diseases in the future. Precigen ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Precigen's Return on Assets (ROA)
Precigen's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Precigen's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Precigen's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Precigen’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Precigen stock
What was the ROA of Precigen compared to the previous year?
The ROA of Precigen has increased by -584.62% compared to the previous year.
What consequences do high ROA have for investors of Precigen?
A high ROA is advantageous for investors of Precigen, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Precigen?
A low ROA can be unfavorable for investors of Precigen as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Precigen affect the company?
An increase in ROA of Precigen can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Precigen impact the company?
A reduction in the ROA of Precigen can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Precigen?
Some factors that can influence the ROA of Precigen include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Precigen important for investors?
The ROA of Precigen is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Precigen take to improve ROA?
To improve ROA, Precigen can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Precigen pay?
Over the past 12 months, Precigen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Precigen is expected to pay a dividend of 0 USD.
What is the dividend yield of Precigen?
The current dividend yield of Precigen is .
When does Precigen pay dividends?
Precigen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Precigen?
Precigen paid dividends every year for the past 0 years.
What is the dividend of Precigen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Precigen located?
Precigen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Precigen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Precigen from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.
When did Precigen pay the last dividend?
The last dividend was paid out on 10/21/2024.
What was the dividend of Precigen in the year 2023?
In the year 2023, Precigen distributed 0 USD as dividends.
In which currency does Precigen pay out the dividend?
The dividends of Precigen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Precigen
Our stock analysis for Precigen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Precigen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
